Top Markets
#1 Bitway Bitway +50.82%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.43%
#3 Pons Pons +36.47%
#4 Starpower Starpower +29.47%
#5 Mubarak Mubarak +28.46%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.98%
#7 Ocean Protocol Ocean Protocol +22.74%
#8 StonkBroker StonkBroker +21.51%
#9 SkyAI SkyAI +20.24%
#10 PondCoin PondCoin +18.22%
Coin of the day
Bitway Bitway
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd

SynCore Biotechnology Co.,Ltd

4192
Helyezés a részvények között #29318
SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the... SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the development and commercialization of biotechnology services, alongside offering expertise in food advisory and medicine inspection. The company's robust pipeline includes several promising drug candidates. Among its novel chemical entities (NCEs), SB01 is an injectable anti-cancer compound currently undergoing Phase II clinical trials for head and neck cancer. Another anti-cancer NCE, SB02, is in preclinical development, targeting stomach cancer. Beyond novel compounds, SynCore also markets established pharmaceutical solutions. This includes SB03-Veregen, an ointment prescribed for external genital and perianal warts. Its portfolio further extends to SB04, a conventional medication for age-related macular degeneration, presently in Phase II clinical studies. Additionally, SynCore is advancing SB05-EndoTAG, an established drug undergoing Phase III clinical trials for the treatment of both pancreatic cancer and triple-negative breast cancer. In a related venture, the company distributes epiCam brand cameras, which are designed for recording the progression of ophthalmic diseases. SynCore maintains strategic collaborations with notable entities such as Medigene AG, MacuCLEAR Inc., Sinphar Pharmaceutical Co., Ltd., and The National Health Research Institutes. Founded in 2008, SynCore Biotechnology Co.,Ltd is headquartered in Yilan City, Taiwan, and operates as a subsidiary of Sinphar Pharmaceutical Co., Ltd.
Részvényárfolyam
$0.62008105
Utolsó szinkronizálás: 2026-08-18
Piaci kapitalizáció
$21.81M
Változás (1 nap)
0.26%
Változás (1 év)
-31.95%
Ország
TW
Kereskedés SynCore Biotechnology Co.,Ltd (4192)

Kategória

Healthcare
EPS SynCore Biotechnology Co.,Ltd (4192) részvényre
EPS 2026 dátummal, TTM: 0
SynCore Biotechnology Co.,Ltd legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi EPS mutatója (TTM) 0. 2026 végén a vállalat EPS mutatója 0 volt, megegyezik a 2026 év EPS értékéhez, amely 0 volt.
SynCore Biotechnology Co.,Ltd EPS története 2026 és 2026 között
EPS minden év végén
Év EPS Változtassa meg
Nincs elég adat a megadott dátumokhoz.
EPS hasonló cégek vagy versenytársak esetén
Vállalat EPS EPS különbség Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH